(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
What happened in 'Wicked' part 1 and will there be a 3rd movie? Recap and what Ariana Grande, Jon M. Chu have said about a sequel. - 2Figure out how to Consolidate All encompassing Practices with a Degree in Brain research
- 3Investigating the World's Chief Authentic Urban communities to Visit
- 4Zelensky confidant dismissed from further posts amid bribery scandal
- 55 Indoor Plants That Further develop Air Quality
- Vote In favor of Your #1 Compelling Female Producer
- FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths
- Parents who delay baby's first vaccines also likely to skip measles shots
- Israel, Gulf states report fresh missile and drone attacks
- NASA releases stunning first images of Earth taken by the Artemis II astronauts
- 3 Italian City Cars That Outsmarted Regulations and Rivals
- Members of Kenya-led security mission in Haiti were involved in rapes, U.N. says
- Figure out How to Track and Anticipate Future Cd Rates
- I’m a doctor. Here are 10 science-backed tips to help you get healthier.
